<?xml version="1.0" encoding="UTF-8"?> 
		<rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/">
		  <channel>
		    <image>
			<title>patentstorm.us</title>
			<width>258</width>
			<height>85</height>
			<link>http://www.patentstorm.us/</link>
			<url>http://www.patentstorm.us/images/logo.gif</url>
			</image>
					
		    <title>PatentStorm ->  Applications -> Organic compounds -- part of the class 532-570 series</title>
		    <link>http://www.patentstorm.us/rss/class/applications/rss-558.xml</link>
		    <description>Recent patent applications filings in USPTO Class 558 Organic compounds -- part of the class 532-570 series.</description>
		    <pubDate>Thu, 9 Feb 2012 15:01:51</pubDate>
		    <managingEditor>patents@patentstorm.us</managingEditor>
		    <language>en</language><item>
			         <title><![CDATA[HYDROCYANATION OF 2-PENTENENITRILE]]></title>
			         <link>http://www.patentstorm.us/applications/20120035387/description.html</link>
			         <description><![CDATA[<ul><li><strong>Application Number:</strong> &nbsp;20120035387</li><li><strong>Publication Date:</strong> &nbsp;2012-02-09</li><li><strong>Inventors:</strong> &nbsp;McKinney, Ronald J.; Lenges, Christian P.; Tam, Wilson; Garner, James Michael</li></ul>The invention provides a process for hydrocyanation, comprising: contacting 2-pentenenitrile with hydrogen cyanide at a temperature in the range of about 0° C. to about 150° C. in the presence of at least one Lewis acid promoter and a catalyst precursor composition, wherein the catalyst precursor composition comprises a zero-valent nickel and at least one bidentate phosphite ligand selected from a member of the group represented by Formula I and Formula II, in which all like reference ...<br />]]></description>		         
			         <guid isPermaLink="false">20120035387</guid>
			      </item>
<item>
			         <title><![CDATA[METHOD FOR PREPARATION OF AND COMPOSITIONS OF LOW FOAM, NON-GELLING, SURFACTANTS]]></title>
			         <link>http://www.patentstorm.us/applications/20120035386/description.html</link>
			         <description><![CDATA[<ul><li><strong>Application Number:</strong> &nbsp;20120035386</li><li><strong>Publication Date:</strong> &nbsp;2012-02-09</li><li><strong>Inventor:</strong> &nbsp;Nguyen, Giao Vinh</li></ul>Low foam, non-gelling surfactants include certain non-ionic alcohol ethoxylate surfactants and anionic ether sulfate surfactants formed therefrom, and processes for preparing the same. Also included are agricultural formulations including agriculturally active ingredients in combination with certain anion ether sulfate ...<br />]]></description>		         
			         <guid isPermaLink="false">20120035386</guid>
			      </item>
<item>
			         <title><![CDATA[ORGANOPHOSPHORUS COMPOUNDS, CATALYTIC SYSTEMS COMPRISING SAID COMPOUNDS AND METHOD OF HYDROCYANATION OR OF HYDROFORMYLATION USING SAID CATALYTIC SYSTEMS]]></title>
			         <link>http://www.patentstorm.us/applications/20120035377/description.html</link>
			         <description><![CDATA[<ul><li><strong>Application Number:</strong> &nbsp;20120035377</li><li><strong>Publication Date:</strong> &nbsp;2012-02-09</li><li><strong>Inventors:</strong> &nbsp;Mastroianni, Sergio; Mikhel, Igor; Pringle, Paul</li></ul>Organophosphorus compounds, catalytic systems comprising a metallic element forming a complex with the organophosphorus compounds and methods of hydrocyanation and of hydroformylation employed in the presence of the catalytic systems are ...<br />]]></description>		         
			         <guid isPermaLink="false">20120035377</guid>
			      </item>
<item>
			         <title><![CDATA[Controlled Release of Nitric Oxide And Drugs From Functionalized Macromers And Oligomers]]></title>
			         <link>http://www.patentstorm.us/applications/20120035259/description.html</link>
			         <description><![CDATA[<ul><li><strong>Application Number:</strong> &nbsp;20120035259</li><li><strong>Publication Date:</strong> &nbsp;2012-02-09</li><li><strong>Inventor:</strong> &nbsp;Bezwada, Rao S.</li></ul>The present invention provides NO and, optionally, drug releasing macromers and oligomers wherein the drug molecule and NO releasing moiety are linked an absorbable macromer or oligomeric chain susceptible to hydrolytic degradation and wherein the macromer or oligomer comprises of repeat units derived from safe and biocompatible molecules such as glycolic acid, lactic acid, caprolactone and p-dioxanone. Furthermore, the present invention relates to controlled release of nitric oxide (NO) and/or ...<br />]]></description>		         
			         <guid isPermaLink="false">20120035259</guid>
			      </item>
<item>
			         <title><![CDATA[GAMMA-AMINO-BUTYRIC ACID DERIVATIVES AS GABAB RECEPTOR LIGANDS]]></title>
			         <link>http://www.patentstorm.us/applications/20120035139/description.html</link>
			         <description><![CDATA[<ul><li><strong>Application Number:</strong> &nbsp;20120035139</li><li><strong>Publication Date:</strong> &nbsp;2012-02-09</li><li><strong>Inventors:</strong> &nbsp;Phan, Thu; Xu, Feng; Peng, Ge; Wustrow, David J.; Gallop, Mark A.; Dilip, Usha</li></ul>Gamma-amino-butyric acid derivatives that are GABA<sub>B </sub>receptor ligands, pharmaceutical compositions comprising such derivatives, and methods of using such derivatives and pharmaceutical compositions thereof for treating diseases are ...<br />]]></description>		         
			         <guid isPermaLink="false">20120035139</guid>
			      </item>
<item>
			         <title><![CDATA[BORON-CONTAINING SMALL MOLECULES]]></title>
			         <link>http://www.patentstorm.us/applications/20120035132/description.html</link>
			         <description><![CDATA[<ul><li><strong>Application Number:</strong> &nbsp;20120035132</li><li><strong>Publication Date:</strong> &nbsp;2012-02-09</li><li><strong>Inventors:</strong> &nbsp;Jarnagin, Kurt; Akama, Tsutomu</li></ul>Compounds, pharmaceutical formulations, and methods of treating anti-inflammatory conditions and/or helminth-associated diseases are ...<br />]]></description>		         
			         <guid isPermaLink="false">20120035132</guid>
			      </item>
<item>
			         <title><![CDATA[METHODS AND COMPOSITIONS FOR IMPROVING IMMUNE RESPONSE BY A NUTRACEUTICAL ANTIOXIDANT]]></title>
			         <link>http://www.patentstorm.us/applications/20120034266/description.html</link>
			         <description><![CDATA[<ul><li><strong>Application Number:</strong> &nbsp;20120034266</li><li><strong>Publication Date:</strong> &nbsp;2012-02-09</li><li><strong>Inventors:</strong> &nbsp;Nel, Andre E.; Kim, Hyon-Jeen</li></ul>The present invention provides a new means of restoring the immune system in aging and immunocompromised individuals using an antioxidant nutraceutical. The nutraceutical stimulates the aging immune system through the Nrf2 master gene regulatory pathway. The invention is based in part on the discovery that the Nrf2 has antioxidant and immune restorative activity. The nutraceutical improves function of both the innate and adaptive immune ...<br />]]></description>		         
			         <guid isPermaLink="false">20120034266</guid>
			      </item>
<item>
			         <title><![CDATA[METHOD FOR PRODUCING HIGH PURITY TERMINAL OLEFIN COMPOUND]]></title>
			         <link>http://www.patentstorm.us/applications/20120029229/description.html</link>
			         <description><![CDATA[<ul><li><strong>Application Number:</strong> &nbsp;20120029229</li><li><strong>Publication Date:</strong> &nbsp;2012-02-02</li><li><strong>Inventors:</strong> &nbsp;Miyoshi, Kei; Asanuma, Goro</li></ul>An industrially advantageous method for producing a high purity terminal olefin is disclosed, comprising the steps of (a) contacting a mixture comprising a terminal olefin represented by formula (1):</p>
<p id="p-0002" num="0000">
</p>
<p id="p-0003" num="0000">and one or more corresponding internal olefins as impurities, with a brominating agent in the presence of water or an alcohol, to convert the internal olefin(s) to compound(s) having a higher boiling point than the terminal olefin; and ...<br />]]></description>		         
			         <guid isPermaLink="false">20120029229</guid>
			      </item>
<item>
			         <title><![CDATA[DMAPN Having a Low DGN Content and a Process for Preparing DMAPA from DMAPN Having a Low DGN Content]]></title>
			         <link>http://www.patentstorm.us/applications/20120029225/description.html</link>
			         <description><![CDATA[<ul><li><strong>Application Number:</strong> &nbsp;20120029225</li><li><strong>Publication Date:</strong> &nbsp;2012-02-02</li><li><strong>Inventors:</strong> &nbsp;Mägerlein, Wolfgang; Köhler, Ulrich; Eberhardt, Jan; Melder, Johann-Peter; Hahn, Thilo; Kreitschmann, Mirko; Herbrecht, Dominik</li></ul>The present invention relates to a process for preparing 3-dimethylaminopropylamine (DMAPA) by reacting 3-dimethylaminopropionitrile (DMAPN) with hydrogen in the presence of a catalyst, wherein the DMAPN used has a content of 2-(dimethylaminomethyl)glutaronitrile (DGN) of 300 ppm by weight or less, based on the DMAPN used.</p>
<p id="p-0002" num="0000">Furthermore, the present invention relates to mixtures of DMAPN and DGN, wherein the weight ratio of DMAPN to DGN is in the range from 1 000 ...<br />]]></description>		         
			         <guid isPermaLink="false">20120029225</guid>
			      </item>
<item>
			         <title><![CDATA[PROCESS FOR THE PREPARATION OF HALOGENATED ARYL PHOSPHONATES]]></title>
			         <link>http://www.patentstorm.us/applications/20120029224/description.html</link>
			         <description><![CDATA[<ul><li><strong>Application Number:</strong> &nbsp;20120029224</li><li><strong>Publication Date:</strong> &nbsp;2012-02-02</li><li><strong>Inventors:</strong> &nbsp;Peled, Michael; Shoshan, Asher; Mazor, Royi</li></ul>A process for preparing halogen-substituted aryl phosphonates represented by formula (I): wherein each Hal independently represents halogen; k is 1 or 2; n is an integer between 1 and 5, inclusive; m is an integer between 1 and 3, inclusive; and R is a straight or branched C1-C5 alkyl group which may be optionally substituted with one or more halogen atoms, which process comprises reacting under heating a compound represented by the following formula: wherein X is a leaving group, with trialkyl ...<br />]]></description>		         
			         <guid isPermaLink="false">20120029224</guid>
			      </item>
<item>
			         <title><![CDATA[METHOD FOR PRODUCTION OF SUBSTITUTED ALKYL MALONIC ESTERS AND DERIVATIVES THEREOF]]></title>
			         <link>http://www.patentstorm.us/applications/20120029223/description.html</link>
			         <description><![CDATA[<ul><li><strong>Application Number:</strong> &nbsp;20120029223</li><li><strong>Publication Date:</strong> &nbsp;2012-02-02</li><li><strong>Inventors:</strong> &nbsp;Friedman, Gad; Stadelmaier, Andreas</li></ul>Substituted alkyl methyl malonate compounds are produced in an essentially one step method, the method suitable for large scale production of alkyl malonate compounds. According to one embodiment the method comprises reacting a methyl malonate with a di-functional, doubly tosylated, alkyl ...<br />]]></description>		         
			         <guid isPermaLink="false">20120029223</guid>
			      </item>
<item>
			         <title><![CDATA[Catalytic Wittig and Mitsunobu Reactions]]></title>
			         <link>http://www.patentstorm.us/applications/20120029211/description.html</link>
			         <description><![CDATA[<ul><li><strong>Application Number:</strong> &nbsp;20120029211</li><li><strong>Publication Date:</strong> &nbsp;2012-02-02</li><li><strong>Inventor:</strong> &nbsp;O'Brien, Christopher J.</li></ul>A catalytic Wittig method utilizing a phosphine including the steps of providing a phosphine oxide precatalyst and reducing the phosphine oxide precatalyst to produce the phosphine; forming a phosphonium ylide precursor from the phosphine and a reactant; generating a phosphonium ylide from the phosphonium ylide precursor; reacting the phosphonium ylide precursor with the aldehyde, ketone, or ester to form the olefin and the phosphine oxide which then reenters the cycle. The invention is also ...<br />]]></description>		         
			         <guid isPermaLink="false">20120029211</guid>
			      </item>
<item>
			         <title><![CDATA[Pyrazole Derivatives]]></title>
			         <link>http://www.patentstorm.us/applications/20120029192/description.html</link>
			         <description><![CDATA[<ul><li><strong>Application Number:</strong> &nbsp;20120029192</li><li><strong>Publication Date:</strong> &nbsp;2012-02-02</li><li><strong>Inventors:</strong> &nbsp;Jones, Lyn Howard; Price, David Anthony; Selby, Matthew Duncan; Mowbray, Charles Eric; Stupple, Paul Anthony</li></ul>This invention relates to pyrazole derivatives of formula (I)</p>
<p id="p-0002" num="0000">
</p>
<p id="p-0003" num="0000">or pharmaceutically acceptable salts, solvates or derivatives thereof, and to processes for the preparation thereof, intermediates used in their preparation of, compositions containing them and the uses of such derivatives. The compounds of the present invention bind to the enzyme reverse transcriptase and are modulators, especially inhibitors thereof. As such, the ...<br />]]></description>		         
			         <guid isPermaLink="false">20120029192</guid>
			      </item>
<item>
			         <title><![CDATA[Novel calcium salts of Compound as Anti-Inflammatory, Immunomodulatory and Anti-Proliferatory Agents]]></title>
			         <link>http://www.patentstorm.us/applications/20120029034/description.html</link>
			         <description><![CDATA[<ul><li><strong>Application Number:</strong> &nbsp;20120029034</li><li><strong>Publication Date:</strong> &nbsp;2012-02-02</li><li><strong>Inventors:</strong> &nbsp;VITT, Daniel; AMMENDOLA, Aldo; DIEDERICHS, Julia; LEBAN, Johann</li></ul>The present invention relates to calcium salts of compounds of the general formula (I)</p>
<p id="p-0002" num="0000">
<ul id="ul0001" list-style="none">
    <li id="ul0001-0001" num="0000">
    <ul id="ul0002" list-style="none">
        <li id="ul0002-0001" num="0000">wherein</li>
        <li id="ul0002-0002" num="0000">X is selected from the group consisting of CH<sub>2</sub>, S, or O;</li>
        <li id="ul0002-0003" num="0000">D is O or S;</li>
        <li id="ul0002-0004" ...<br />]]></description>		         
			         <guid isPermaLink="false">20120029034</guid>
			      </item>
<item>
			         <title><![CDATA[PROCESS FOR THE PREPARATION OF ALOGLIPTIN]]></title>
			         <link>http://www.patentstorm.us/applications/20120029000/description.html</link>
			         <description><![CDATA[<ul><li><strong>Application Number:</strong> &nbsp;20120029000</li><li><strong>Publication Date:</strong> &nbsp;2012-02-02</li><li><strong>Inventors:</strong> &nbsp;Mizhiritskii, Michael; Marom, Ehud; Rubnov, Shai</li></ul>The present invention is based on the discovery of a process for preparing pyrimidin-dione compounds, especially alogliptin and its derivatives, which comprises the reaction of a urea derivative of formula (VIII) with a malonic acid or its derivatives to form intermediates of formulae (VII) or (VII-A), which are subsequently converted to a compound of formula (II) upon introduction of a leaving group X. Compound (II) then reacts with an amine to form compound (I), which is optionally converted ...<br />]]></description>		         
			         <guid isPermaLink="false">20120029000</guid>
			      </item>
<item>
			         <title><![CDATA[Inhibitors Of The Influenza A Virus M2 Proton Channel]]></title>
			         <link>http://www.patentstorm.us/applications/20120028957/description.html</link>
			         <description><![CDATA[<ul><li><strong>Application Number:</strong> &nbsp;20120028957</li><li><strong>Publication Date:</strong> &nbsp;2012-02-02</li><li><strong>Inventors:</strong> &nbsp;Wang, Jun; DeGrado, William F.</li></ul>Provided are compounds that are capable of modulating the activity of the influenza A virus via interaction with the M2 transmembrane protein. Also provided are methods for treating an influenza A-affected disease state or infection comprising administering a composition comprising one or more compounds that have been identified as being capable of interaction with the M2 ...<br />]]></description>		         
			         <guid isPermaLink="false">20120028957</guid>
			      </item>
<item>
			         <title><![CDATA[ANTHRAQUINONE BASED NEAR IR EMITTING COMPOUNDS AND USES THEREOF]]></title>
			         <link>http://www.patentstorm.us/applications/20120028249/description.html</link>
			         <description><![CDATA[<ul><li><strong>Application Number:</strong> &nbsp;20120028249</li><li><strong>Publication Date:</strong> &nbsp;2012-02-02</li><li><strong>Inventors:</strong> &nbsp;Bradford, Jolene; Huang, Shih-Jung; Yue, Stephen</li></ul>Disclosed are near IR emitting fluorescent compounds; methods of making and kits containing the described compounds; and their use in fluorescence-based detection of biological ...<br />]]></description>		         
			         <guid isPermaLink="false">20120028249</guid>
			      </item>
<item>
			         <title><![CDATA[Electrolyte for Electrochemical Device, Electrolyte Solution Using Same, and Non-Aqueous Electrolyte Battery]]></title>
			         <link>http://www.patentstorm.us/applications/20120028132/description.html</link>
			         <description><![CDATA[<ul><li><strong>Application Number:</strong> &nbsp;20120028132</li><li><strong>Publication Date:</strong> &nbsp;2012-02-02</li><li><strong>Inventors:</strong> &nbsp;Tsujioka, Shoichi; Fujiwara, Aiichiro; Mitsui, Toshinori; Kondo, Yuki</li></ul>[Summary] An object of the present invention is to find a new electrolyte having a characteristics for the electrolyte for an electrochemical device and to provide excellent electrolytic solution for a nonaqueous electrolyte battery and nonaqueous electrolyte battery which use this.</p>
<p id="p-0002" num="0000">[Solving Means] To provide an electrolyte for an electrochemical device, having a chemical structure formula represented by a general formula (1).</p>
<p id="p-0003" num="0000">
</p>
<p ...<br />]]></description>		         
			         <guid isPermaLink="false">20120028132</guid>
			      </item>
<item>
			         <title><![CDATA[IONIC CONDUCTIVE SIDE-CHAIN-TYPE POLYMER ELECTROLYTE, PRECURSOR THEREOF, AND LITHIUM SECONDARY BATTERY]]></title>
			         <link>http://www.patentstorm.us/applications/20120028093/description.html</link>
			         <description><![CDATA[<ul><li><strong>Application Number:</strong> &nbsp;20120028093</li><li><strong>Publication Date:</strong> &nbsp;2012-02-02</li><li><strong>Inventors:</strong> &nbsp;NISHIMURA, Shin; SATOU, Akira</li></ul>This invention provides a side-chain-type polymer electrolyte exhibiting high ionic conductivity and a lithium secondary battery using the same. Such side-chain-type polymer electrolyte comprises a polymer structural unit represented by formula (1):</p>
<p id="p-0002" num="0000">
</p>
<p id="p-0003" num="0000">wherein R<sub>p </sub>represents an organic group obtained via polymerization of monomer compounds containing polymerizable unsaturated linkages or a polymerized organic group containing ...<br />]]></description>		         
			         <guid isPermaLink="false">20120028093</guid>
			      </item>
<item>
			         <title><![CDATA[INTRAOCULAR LENSES TREATED WITH ALKYLPHOSPHOCHOLINES FOR PHARMACOLOGICAL AFTERCATARACT PROPHYLAXIS]]></title>
			         <link>http://www.patentstorm.us/applications/20120027812/description.html</link>
			         <description><![CDATA[<ul><li><strong>Application Number:</strong> &nbsp;20120027812</li><li><strong>Publication Date:</strong> &nbsp;2012-02-02</li><li><strong>Inventors:</strong> &nbsp;Eibl, Hansjörg; Eibl-Lindner, Kirsten; Kampik, Anselm</li></ul>The invention relates to ophthalmological implants which comprise alkylphosphocholines. Implants of this type may in particular advantageously be used for the prophylaxis of ...<br />]]></description>		         
			         <guid isPermaLink="false">20120027812</guid>
			      </item>
<item>
			         <title><![CDATA[PROCESS FOR THE PREPARATION OF 2,4,6-OCTATRIENE-1-OIC ACID AND 2,4,6-OCTATRIENE-1-OL]]></title>
			         <link>http://www.patentstorm.us/applications/20120022282/description.html</link>
			         <description><![CDATA[<ul><li><strong>Application Number:</strong> &nbsp;20120022282</li><li><strong>Publication Date:</strong> &nbsp;2012-01-26</li><li><strong>Inventors:</strong> &nbsp;Giuliani, Giammaria; Benedusi, Anna; Milanese, Aberto</li></ul>The present invention concerns a process for synthesis of 2,4,6-octatriene-1-oic acid and 2,4,6-octatriene-1-ol, which comprises the following stages:
<ul id="ul0001" list-style="none">
    <li id="ul0001-0001" num="0000">
    <ul id="ul0002" list-style="none">
        <li id="ul0002-0001" num="0000">a) reaction between 2,4-trans-hexadienal and triethyl phosphonoacetate to give ethyl 2,4,6-trans-octatrienoate;</li>
        <li id="ul0002-0002" num="0000">b) alkaline hydrolysis of ethyl ...<br />]]></description>		         
			         <guid isPermaLink="false">20120022282</guid>
			      </item>
<item>
			         <title><![CDATA[PROCESS FOR PRODUCING (S)-3-[(1-DIMETHYLAMINO)ETHYL] PHENYL-N-ETHYL-N-METHYL-CARBAMATE VIA NOVEL INTERMEDIATES]]></title>
			         <link>http://www.patentstorm.us/applications/20120022281/description.html</link>
			         <description><![CDATA[<ul><li><strong>Application Number:</strong> &nbsp;20120022281</li><li><strong>Publication Date:</strong> &nbsp;2012-01-26</li><li><strong>Inventors:</strong> &nbsp;Dubey, Shailendra Kumar; Bansal, Vikas; Pannu, Kamaljeet; Dubey, Sushil Kumar</li></ul>Disclosed herein are novel intermediates and process for large scale production of (S)-3-[(1-dimethylamino)ethyl]phenyl-N-ethyl-N-methyl-carbamate (rivastigmine) or its pharmaceutically acceptable salts employing the novel intermediates. Further provided are methods for producing the novel intermediates ...<br />]]></description>		         
			         <guid isPermaLink="false">20120022281</guid>
			      </item>
<item>
			         <title><![CDATA[NOVEL METHOD FOR PRODUCING OPTICALLY ACTIVE PYRROLIDINE COMPOUND]]></title>
			         <link>http://www.patentstorm.us/applications/20120022271/description.html</link>
			         <description><![CDATA[<ul><li><strong>Application Number:</strong> &nbsp;20120022271</li><li><strong>Publication Date:</strong> &nbsp;2012-01-26</li><li><strong>Inventors:</strong> &nbsp;Kikuchi, Takashi; Ohigashi, Atsushi</li></ul>[Object]</p>
<p id="p-0002" num="0000">A novel method for producing an optically active pyrrolidine compound, which is useful as a production intermediate of a pharmaceutical, and a production intermediate thereof, is provided.</p>
<p id="p-0003" num="0000">[Means for Solution]</p>
<p id="p-0004" num="0000">According to the production method of the present invention, a chloro compound that is a key intermediate can be produced efficiently industrially by subjecting a mixture of regioisomers ...<br />]]></description>		         
			         <guid isPermaLink="false">20120022271</guid>
			      </item>
<item>
			         <title><![CDATA[PROCESSES FOR PREPARING HIV REVERSE TRANSCRIPTASE INHIBITORS]]></title>
			         <link>http://www.patentstorm.us/applications/20120022257/description.html</link>
			         <description><![CDATA[<ul><li><strong>Application Number:</strong> &nbsp;20120022257</li><li><strong>Publication Date:</strong> &nbsp;2012-01-26</li><li><strong>Inventors:</strong> &nbsp;Pfeiffer, Steven; Heumann, Stacey; Levins, Christopher M.; Tang, Donald</li></ul>Disclosed is a method for preparing HIV reverse transcriptase inhibitors which inhibit replication of HIV in HIV infected cells, and novel intermediate compounds used ...<br />]]></description>		         
			         <guid isPermaLink="false">20120022257</guid>
			      </item>
<item>
			         <title><![CDATA[PHOSPHINE LIGANDS FOR CATALYTIC REACTIONS]]></title>
			         <link>http://www.patentstorm.us/applications/20120022252/description.html</link>
			         <description><![CDATA[<ul><li><strong>Application Number:</strong> &nbsp;20120022252</li><li><strong>Publication Date:</strong> &nbsp;2012-01-26</li><li><strong>Inventors:</strong> &nbsp;Shekhar, Shashank; Franczyk, Thaddeus S.; Barnes, David M.; Dunn, Travis B.; Haight, Anthony R.; Chan, Vincent S.</li></ul>The disclosure is directed to: (a) phosphacycle ligands; (b) methods of using such phosphacycle ligands in bond forming reactions; and (c) methods of preparing phosphacycle ...<br />]]></description>		         
			         <guid isPermaLink="false">20120022252</guid>
			      </item>
<item>
			         <title><![CDATA[WATER MISCIBLE SOLVENT BASED PROCESS FOR PURIFYING A BISPHOSPHATE]]></title>
			         <link>http://www.patentstorm.us/applications/20120022193/description.html</link>
			         <description><![CDATA[<ul><li><strong>Application Number:</strong> &nbsp;20120022193</li><li><strong>Publication Date:</strong> &nbsp;2012-01-26</li><li><strong>Inventors:</strong> &nbsp;Zilberman, Joseph; Canfi, Dorit; Gregor, Andrew; Piotrowski, Andrew</li></ul>There is provided herein a process for purifying bisphosphate comprising solvating a molten bisphosphate in a mixture of water and water miscible solvent; cooling the solution over a period and to a temperature that provides for crystallization of solid product; increasing the pH of the solution prior to, and/or during, and/or after the initiation of crystallization, and/or after crystallization, by the addition of a base; and after crystallization is complete, separating solid product from the ...<br />]]></description>		         
			         <guid isPermaLink="false">20120022193</guid>
			      </item>
<item>
			         <title><![CDATA[COMPOSITIONS AND METHODS FOR THE TREATMENT OF PATHOLOGICAL CONDITION(S) RELATED TO GPR35 AND/OR GPR35-HERG COMPLEX]]></title>
			         <link>http://www.patentstorm.us/applications/20120022116/description.html</link>
			         <description><![CDATA[<ul><li><strong>Application Number:</strong> &nbsp;20120022116</li><li><strong>Publication Date:</strong> &nbsp;2012-01-26</li><li><strong>Inventors:</strong> &nbsp;Sun, Haiyan; Niu, Weijun; Fang, Ye; He, Mingqian; Deng, Huayun; Hu, Haibei</li></ul>Disclosed are compositions and methods for the prevention and/or treatment of diseases which are pathophysiologically related to GPR35, and/or GPR35-hERG signaling complex. For example, disclosed are compounds for preventing and/or treating diseases which are pathophysiologically related to GPR35 in a subject. The compounds having a formula (I), (II) or (III):</p>
<p id="p-0002" ...<br />]]></description>		         
			         <guid isPermaLink="false">20120022116</guid>
			      </item>
<item>
			         <title><![CDATA[NOVEL HERBICIDES]]></title>
			         <link>http://www.patentstorm.us/applications/20120021912/description.html</link>
			         <description><![CDATA[<ul><li><strong>Application Number:</strong> &nbsp;20120021912</li><li><strong>Publication Date:</strong> &nbsp;2012-01-26</li><li><strong>Inventors:</strong> &nbsp;Mathews, Christopher John; Scutt, James Nicholas; Finney, John; Robinson, Louisa; Delaney, John Stephen</li></ul>Compounds of Formula (I), wherein the substituents are as defined in claim <b>1</b>, are suitable for use as herbicides.</p>
<p id="p-0002" ...<br />]]></description>		         
			         <guid isPermaLink="false">20120021912</guid>
			      </item>
<item>
			         <title><![CDATA[FUNGICIDAL COMPOSITIONS INCLUDING HYDRAZONE DERIVATIVES AND COPPER]]></title>
			         <link>http://www.patentstorm.us/applications/20120021065/description.html</link>
			         <description><![CDATA[<ul><li><strong>Application Number:</strong> &nbsp;20120021065</li><li><strong>Publication Date:</strong> &nbsp;2012-01-26</li><li><strong>Inventors:</strong> &nbsp;Webster, Jeffery D.; Siddall, Thomas L.; Ruiz, James M.; Young, David H.; Shaber, Steven Howard; Avila-Adame, Cruz; Breaux, Nneka T.</li></ul>The present invention relates to the use of hydrazone compounds and copper for controlling the growth of ...<br />]]></description>		         
			         <guid isPermaLink="false">20120021065</guid>
			      </item>
<item>
			         <title><![CDATA[Novel Tricyanoborates]]></title>
			         <link>http://www.patentstorm.us/applications/20120018676/description.html</link>
			         <description><![CDATA[<ul><li><strong>Application Number:</strong> &nbsp;20120018676</li><li><strong>Publication Date:</strong> &nbsp;2012-01-26</li><li><strong>Inventors:</strong> &nbsp;Wenger, Wolfgang; Zur Taschler, Cornelia</li></ul>The present invention relates to novel tricyanoborates of the general formula Cat<sup>n+</sup> [B(CN)<sub>3</sub>(XR<sup>1</sup>)]—<sub>n</sub>, wherein R<sup>1 </sup>is C<sub>1-6 </sub>alkyl, C<sub>2-6 </sub>alkenyl, C<sub>6-10 </sub>aryl or benzyl; X is oxygen or sulfur; and Cat<sup>n+</sup> is a cation with n being 1 or 2, which is selected from the group consisting of an inorganic cation and an organic cation; and also their preparation and ...<br />]]></description>		         
			         <guid isPermaLink="false">20120018676</guid>
			      </item>
<item>
			         <title><![CDATA[Process for Producing 3-(2-Cyano-1-propenyl)-2,2- Dimethylcyclopropanecarboxylic Acid or Salt Thereof]]></title>
			         <link>http://www.patentstorm.us/applications/20120016150/description.html</link>
			         <description><![CDATA[<ul><li><strong>Application Number:</strong> &nbsp;20120016150</li><li><strong>Publication Date:</strong> &nbsp;2012-01-19</li><li><strong>Inventors:</strong> &nbsp;Uekawa, Toru; Ohshita, Jun; Komoto, Ichiro; Yoshikawa, Kouji</li></ul>A process for producing comprising reacting a 3-formyl-2,2-dimethylcyclopropanecarboxylate and propionitrile in the presence of a base to obtain 3-(2-cyano-1-propenyl)-2,2-dimethylcyclopropanecarboxylic acid or its ...<br />]]></description>		         
			         <guid isPermaLink="false">20120016150</guid>
			      </item>
<item>
			         <title><![CDATA[EPOXIDATION CATALYST, A PROCESS FOR PREPARING THE CATALYST, ANDA PROCESS FOR THE PROUCTION OF AN OLEFIN OXIDE]]></title>
			         <link>http://www.patentstorm.us/applications/20120016143/description.html</link>
			         <description><![CDATA[<ul><li><strong>Application Number:</strong> &nbsp;20120016143</li><li><strong>Publication Date:</strong> &nbsp;2012-01-19</li><li><strong>Inventor:</strong> &nbsp;MATUSZ, Marek</li></ul>A catalyst for the epoxidation of an olefin comprising a carrier and deposited on the carrier, silver, a promoting amount of one or more promoters selected from the group consisting of alkali metals and rhenium and a promoting amount of nickel, wherein the nickel is added as a nickel compound or nickel complex during the initial impregnation along with the silver and other promoters; including a process for preparing the catalyst; a process for preparing an olefin oxide by reacting a feed ...<br />]]></description>		         
			         <guid isPermaLink="false">20120016143</guid>
			      </item>
<item>
			         <title><![CDATA[METHOD FOR PREPARING DIPEPTIDYL PEPTIDASE-IV INHIBITOR AND INTERMEDIATE]]></title>
			         <link>http://www.patentstorm.us/applications/20120016125/description.html</link>
			         <description><![CDATA[<ul><li><strong>Application Number:</strong> &nbsp;20120016125</li><li><strong>Publication Date:</strong> &nbsp;2012-01-19</li><li><strong>Inventors:</strong> &nbsp;Yoo, Moohi; Kwak, Woo Young; Kim, Heung Jae; Min, Jong Pil; Yoon, Tae Hyun; Lim, Geun Gho; Chang, Sun Ki</li></ul>The present invention relates to an improved method for preparing dipeptidyl peptidase-IV inhibitor and intermediate. The present invention is able to reduce preparation costs by using low cost reagents on reaction and is able to be used in mass production by improving ...<br />]]></description>		         
			         <guid isPermaLink="false">20120016125</guid>
			      </item>
<item>
			         <title><![CDATA[ISOTHIOUREA DERIVATIVES OR ISOUREA DERIVATIVES HAVING BACE1 INHIBITORY ACTIVITY]]></title>
			         <link>http://www.patentstorm.us/applications/20120015961/description.html</link>
			         <description><![CDATA[<ul><li><strong>Application Number:</strong> &nbsp;20120015961</li><li><strong>Publication Date:</strong> &nbsp;2012-01-19</li><li><strong>Inventors:</strong> &nbsp;Suzuki, Shinji; Hori, Akihiro; Matsumoto, Sae; Kooriyama, Yuuji; Tamura, Yuusuke</li></ul>The present invention provides, for example, a compound of the following formula (I):</p>
<p id="p-0002" num="0000">
<ul id="ul0001" list-style="none">
    <li id="ul0001-0001" num="0000">wherein R<sup>1 </sup>is substituted amino and the like,</li>
    <li id="ul0001-0002" num="0000">R<sup>2 </sup>is halogen and the like,</li>
    <li id="ul0001-0003" num="0000">R<sup>3 </sup>is substituted or unsubstituted lower alkyl and the like,</li>
    <li id="ul0001-0004" num="0000">R<sup>A </sup>and ...<br />]]></description>		         
			         <guid isPermaLink="false">20120015961</guid>
			      </item>
<item>
			         <title><![CDATA[Spirocyclic nitriles as protease inhibitors]]></title>
			         <link>http://www.patentstorm.us/applications/20120015933/description.html</link>
			         <description><![CDATA[<ul><li><strong>Application Number:</strong> &nbsp;20120015933</li><li><strong>Publication Date:</strong> &nbsp;2012-01-19</li><li><strong>Inventors:</strong> &nbsp;WAGNER, Michael; SCHUDOK, Manfred; BAUER, Armin; KOHLMANN, Anna</li></ul>The invention relates to substituted carbo- and heterocyclic spiro compounds of the formula Ia which inhibit thiol proteases, to processes for their preparation and to the use thereof as ...<br />]]></description>		         
			         <guid isPermaLink="false">20120015933</guid>
			      </item>
<item>
			         <title><![CDATA[ORGANIC LUMINESCENT MEDIUM]]></title>
			         <link>http://www.patentstorm.us/applications/20120013244/description.html</link>
			         <description><![CDATA[<ul><li><strong>Application Number:</strong> &nbsp;20120013244</li><li><strong>Publication Date:</strong> &nbsp;2012-01-19</li><li><strong>Inventors:</strong> &nbsp;Saito, Hiroyuki; Kawamura, Yuichiro; Kawamura, Masahiro; Mizuki, Yumiko</li></ul>An organic luminescent medium including an anthracene derivative represented by the following formula (1) and a compound having at least one electron-attracting group in the molecular structure thereof.</p>
<p id="p-0002" ...<br />]]></description>		         
			         <guid isPermaLink="false">20120013244</guid>
			      </item>
</channel>
		</rss>
